Navigation Links
AMDL, Inc. Named to Deloitte LLC Technology Fast 50
Date:10/24/2008

Company Listed Among North America's Fastest-Growing Companies

TUSTIN, Calif., Oct. 24 /PRNewswire-FirstCall/ -- (http://www.amdl.com) AMDL, Inc. (Amex: ADL), a vertically integrated pharmaceutical company with major operations in China and the US, today announced it has been recognized by Deloitte LLP as the 6th fastest growing Company in Orange County in the prestigious Deloitte Technology Fast 50 Program.

This nationally-recognized program is a ranking by Deloitte LLP of the 50 fastest growing technology, media, telecommunications, and life sciences companies specifically in Orange County and surrounding areas. The company ranked the Top-50 companies based on the highest percentage of revenue growth over five years from 2003-2007. AMDL secured the 6th position by achieving an average 4,100 percent revenue growth during this period. The Company was also recognized earlier this week by the Orange County Business Journal as the #1 fastest-growing public Company in Orange County, achieving over 33,440% revenue growth and more than $26 million in sales in the periods between June 30, 2205 and June 30, 2008.

AMDL's President and CEO Mr. Gary Dreher credits the Company's strong revenue growth to consistent execution on key business initiatives, including the successful marketing, sales, and expanded distribution of high profit products that include the Goodnak(R) anti-aging product line, Domperidone anti-emetic product and various off-label pharmaceuticals. Strong sales of these products have driven AMDL's year-over-year revenue growth by more than 100%, specifically in the past 24 months. The Company has also hit key business milestones over the past 12 months that position the Company for continued growth. This includes success in obtaining regulatory approval by the United States Food and Drug Administration (US FDA) for the AMDL ELISA DR-70(R) (FDP) cancer test.

"Sustaining high revenue growth over five years is an exceptional accomplishment, particularly for an emerging company such as AMDL," said Rob Lucenti, Managing Partner, Orange County Practice, Deloitte & Touche LLP. "We commend AMDL for having shown the strength, vision and tenacity to succeed in today's very competitive life sciences environment and is proud to honor them to Deloitte's Technology Fast 50."

Mr. Gary Dreher, president and CEO of AMDL commented, "Making this list is a tremendous honor for AMDL and a reflection of the hard work and commitment of our China and US-based teams. Our combined efforts have driven the major advancements in our business and subsequently our strong financial performance; and we're focused on continuing the positive path we've paved which includes achieving our targeted sales goal of $26 million in sales in the second half of this year and $38 million for fiscal year 2008."

To qualify for the Technology Fast 50, companies must have had operating revenues of at least $50,000 in 2003 and $5,000,000 in 2007, be headquartered in North America, and be a company that owns proprietary technology or proprietary intellectual property that contributes to a significant portion of the company's operating revenues; or devotes a significant proportion of revenues to the research and development of technology. Using other companies' technology or intellectual property in a unique way does not qualify.

This year's Orange County Technology Fast 50 program is sponsored by Cresa Partners, DLD Insurance Brokers, Stradling Yocca Carlson & Rauth, Union Bank of California, Publicease and Oracle, in association with the Technology Council of Southern California. Companies from the regional Technology Fast 50 programs in the United States and Canada are automatically entered in Deloitte's Technology Fast 500 program, which ranks North America's top 500 fastest growing technology, media, telecommunications and life sciences companies. For more information on Deloitte's Technology Fast 50 or Technology Fast 500 programs, visit http://www.fast500.com.

About AMDL:

Headquartered in Tustin, CA with operations in Shenzhen, Jiangxi, and Jilin, China, AMDL, Inc., along with its subsidiary Jade Pharmaceutical Inc. (JPI), is a vertically integrated bio-pharmaceutical company devoted to the research, development, manufacturing, and marketing of diagnostic, pharmaceutical, nutritional supplement, and cosmetic products. The company employs approximately 320 people in the U.S. and China. The Company has an additional 4 pharmaceutical and diagnostic products under review by various regulatory authorities.

Forward Looking Statements:

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: The statements contained in this document include certain predictions and projections that may be considered forward- looking statements under securities law. These statements involve a number of important risks and uncertainties that could cause actual results to differ materially including, but not limited to, the performance of joint venture partners, as well as other economic, competitive and technological factors involving the Company's operations, markets, services, products, and prices. With respect to AMDL, Inc., except for the historical information contained herein, the matters discussed in this document are forward-looking statements involving risks and uncertainties that could cause actual results to differ materially from those in such forward-looking statements. Potential risks and uncertainties related to the Company's access to additional capital, competition and dependence on key management.

AMDL Contact:

Kristine Szarkowitz

Director-Investor Relations

kszarkowitz@amdl.com

(Tel:) 206.310.5323


'/>"/>
SOURCE AMDL, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. AMDL, Inc. Announces Strategic Realignment
2. AMDL, Inc. to Present at Maxim Group Growth Conference October 7, 2008
3. AMDL, Inc. Closes Private Placement of Convertible Notes
4. The Wall Street Transcript Interviews AMDL, Inc. CEO & President Gary Dreher for Fall Healthcare Issue
5. Rudd Report Highlights AMDL, Inc.s Latest Business Achievements; Supports 2008 Financial Guidance
6. AMDL, Inc. Retains Strategic Growth International Inc. as its Global Investor Relations Advisor
7. Dorin Panescu Named NewCardios Chief Technical Officer
8. MicroCHIPS CEO Named in Popular Sciences Seventh Annual Brilliant 10
9. Dr. Larry Corey Named New Member of the Institutes of Medicine
10. Merck Serono Named as a Top Employer by Science Magazine
11. EMD Serono Named as a Top Employer by Science Magazine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2017)... ... March 27, 2017 , ... Biopsies from non-small ... samples with limited tumor content in a large background of normal or wild ... the need for reliable detection of low abundance somatic mutations, particularly in small ...
(Date:3/27/2017)... The new research portal will give ... reports on Valero Energy , offering extensive market research ... ... (Logo: http://photos.prnewswire.com/prnh/20160330/349511LOGO) The latest trend gaining ... Ethanol today, even though touted as a green alternative to ...
(Date:3/27/2017)... March 27, 2017 DarioHealth Corp. (NASDAQ: DRIO), ... and big data solutions, today announced that it is ... option for U.S. consumers who want to have their ... has signed strategic alliance agreements with partners across the ... benefits, and if approved, will supply and bill the ...
(Date:3/24/2017)... Research and Markets has announced the addition of the "Human ... report to their offering. ... This report analyzes the Global market for Human Embryonic ... are provided for the period 2014 through 2022. Market data and ... The report profiles 25 companies including many key and niche players ...
Breaking Biology Technology:
(Date:3/24/2017)... The Controller General of Immigration from Maldives Mr. Mohamed Anwar ... prestigious international IAIR Award for the most innovative high security ePassport and ... ... Maldives Immigration Controller General, Mr. Mohamed ... the right) have received the IAIR award for the "Most innovative high ...
(Date:3/22/2017)... March 21, 2017   Neurotechnology , a ... technologies, today announced the release of the ... provides improved facial recognition using up to 10 ... single computer. The new version uses deep neural-network-based ... and it utilizes a Graphing Processing Unit (GPU) ...
(Date:3/20/2017)... March 20, 2017 PMD Healthcare announces the ... and Wellness Management System (WMS), a remote, real-time lung ... 2010, PMD Healthcare is a Medical Device, Digital Health, ... dedicated to creating innovative solutions that empower people to ... intent focus, PMD developed the first ever personal spirometer, ...
Breaking Biology News(10 mins):